Intranasal abuse of prescription hydrocodone/acetaminophen results in oronasal fistula: A case report

Journal of Opioid Management

Volumn 5, Issue 6, 2009, Pages 383-385

  Sloan, Paul A ^a   Klimkina, Oksana ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Drug abuse; Hydrocodone; Intranasal opioid use

Indexed keywords

ALPRAZOLAM; HYDROCODONE BITARTRATE PLUS PARACETAMOL; VALACICLOVIR; ACETAMINOPHEN, HYDROCODONE DRUG COMBINATION; HYDROCODONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ANAMNESIS; ARTICLE; BACKACHE; BULIMIA; CASE REPORT; COUNSELING; ELIXIR; FEMALE; FISTULA; FOREIGN BODY; GENITAL HERPES; HUMAN; ORONASAL FISTULA; PALATOPLASTY; PHYSICAL EXAMINATION; POSTOPERATIVE PAIN; PRESCRIPTION; SOFT PALATE; TRAFFIC ACCIDENT; DRUG COMBINATION; INTRANASAL DRUG ADMINISTRATION; LOW BACK PAIN; OPIATE ADDICTION; PATHOLOGY; SPEECH DISORDER; TABLET; TOOTH FISTULA; TREATMENT OUTCOME;

ACETAMINOPHEN; ADMINISTRATION, INTRANASAL; ADULT; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG COMBINATIONS; FEMALE; FOREIGN BODIES; HUMANS; HYDROCODONE; LOW BACK PAIN; OPIOID-RELATED DISORDERS; OROANTRAL FISTULA; SPEECH DISORDERS; TABLETS; TREATMENT OUTCOME;

EID: 75649100579     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2009.0039     Document Type: Article

References (14)

1. Sloan PA, Babul N: Extended-release opioids for the management of chronic non-malignant pain. Expert Opin Drug Deliv. 2006; 3: 489-497.
2. Zacny J, Bigelow G, Compton P, et al.: College on problems of drug dependence taskforce on prescription opioid nonmedical use and abuse: Position statement. Drug Alcohol Depend. 2003; 69: 215-232.
3. Helie F, Fournier J: Destructive lesions of the median line secondary to cocaine abuse. J Otolaryngol. 1997; 26: 67-69.
4. Greene D: Total necrosis of the intranasal structures and soft palate as a result of nasal inhalation of crushed OxyContin. Ear Nose Throat J. 2005; 84: 512-516.
5. Davis WR, Johnson BD: Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008; 92: 267-276.
6. Yewell J, Haydon R, Archer S, et al.: Complications of intranasal prescription narcotic abuse. Ann Otol Rhinol Laryngol. 2002; 111: 174-177.
7. Manchikanti KN, Manchikanti L, Damron KS, et al.: Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice. J Opioid Manage. 2008; 4: 271-283.
8. Sloan PA, Slatkin NE, Ahdieh H: Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study. Support Care Cancer 2005; 13: 57-65.
9. Sloan PA: Oxymorphone in the management of pain. Ther Clin Risk Manage. 2008; 4: 1-11.
10. Chou R, Fanciullo GJ, Fine PG, et al.: Opioid Treatment Guidelines: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.
11. Cicero TJ: Prescription drug abuse and its relationship to pain management. Adv Pain Manage. 2008; 2: 17-29.
12. Reisfield GM, Wilson GR: Are some physicians unwitting enablers of prescription opioid abuse? J Opioid Manage. 2009; 5: 71-73.
13. Michna E, Jamison RN, Pham LD, et al.: Urine toxicology screening among chronic pain patients on opioid therapy: Frequency and predictability of abnormal findings. Clin J Pain. 2007; 23: 173-179.
14. Webster LR, Webster RM: Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med. 2005; 6: 432-442.